Review of preoperative transarterial chemoembolization for resectable hepatocellular carcinoma.

Szczegóły
Abstrakt

Tytuł:: Review of preoperative transarterial chemoembolization for resectable hepatocellular carcinoma.
Autorzy:: Gao ZH; Zhi-Hui Gao, Dou-Sheng Bai, Guo-Qing Jiang, Sheng-Jie Jin, Hepato-bilio-pancreatic Surgery Department, Subei People's Hospital, Yangzhou University, Yangzhou 225001, Jiangsu Province, China.
Bai DS; Zhi-Hui Gao, Dou-Sheng Bai, Guo-Qing Jiang, Sheng-Jie Jin, Hepato-bilio-pancreatic Surgery Department, Subei People's Hospital, Yangzhou University, Yangzhou 225001, Jiangsu Province, China.
Jiang GQ; Zhi-Hui Gao, Dou-Sheng Bai, Guo-Qing Jiang, Sheng-Jie Jin, Hepato-bilio-pancreatic Surgery Department, Subei People's Hospital, Yangzhou University, Yangzhou 225001, Jiangsu Province, China.
Jin SJ; Zhi-Hui Gao, Dou-Sheng Bai, Guo-Qing Jiang, Sheng-Jie Jin, Hepato-bilio-pancreatic Surgery Department, Subei People's Hospital, Yangzhou University, Yangzhou 225001, Jiangsu Province, China.
Źródło:: World journal of hepatology [World J Hepatol] 2015 Jan 27; Vol. 7 (1), pp. 40-3.
Typ publikacji:: Journal Article; Review
Język:: English
Imprint Name(s):: Publication: 2014- : Pleasanton, CA : Baishideng Publishing Group
Original Publication: Beijing, China : Baishideng
References:: Ann Surg. 2009 Feb;249(2):195-202. (PMID: 19212170)
Med Oncol. 2014 Mar;31(3):843. (PMID: 24442426)
Oncology. 2012;82(1):11-8. (PMID: 22269311)
Abdom Imaging. 2014 Oct;39(5):969-78. (PMID: 24740759)
CA Cancer J Clin. 2012 Nov-Dec;62(6):394-9. (PMID: 23070690)
J Cancer Res Clin Oncol. 2014 Jul;140(7):1159-70. (PMID: 24752339)
BMC Gastroenterol. 2014 Jan 10;14:11. (PMID: 24410841)
Ann Surg Oncol. 2012 Sep;19(9):2897-907. (PMID: 22476754)
Liver Cancer. 2014 Mar;3(1):9-17. (PMID: 24804173)
Hepatobiliary Pancreat Dis Int. 2014 Apr;13(2):153-61. (PMID: 24686542)
J Vasc Interv Radiol. 2014 Mar;25(3):371-8. (PMID: 24468045)
Clin Radiol. 2012 Dec;67(12):e105-11. (PMID: 23026725)
Liver Int. 2014 Jul;34(6):e136-43. (PMID: 24451026)
BMC Gastroenterol. 2013 Mar 19;13:51. (PMID: 23509884)
HPB (Oxford). 2012 May;14(5):285-90. (PMID: 22487065)
Dig Dis Sci. 2012 May;57(5):1404-12. (PMID: 22271410)
J Vasc Interv Radiol. 2014 Apr;25(4):567-74. (PMID: 24462006)
J Vasc Interv Radiol. 2013 May;24(5):647-54. (PMID: 23384831)
PLoS One. 2014 Jun 19;9(6):e100305. (PMID: 24945380)
J Gastrointest Surg. 2014 Mar;18(3):555-61. (PMID: 24420729)
Clin Gastroenterol Hepatol. 2013 May;11(5):572-8. (PMID: 23333661)
Ann Surg Oncol. 2013 Apr;20(4):1216-22. (PMID: 23104706)
Endocrine. 2014 Sep;47(1):177-82. (PMID: 24385266)
Ann Surg Oncol. 2014 Jun;21(6):1825-33. (PMID: 24499831)
Am J Gastroenterol. 2014 Aug;109(8):1234-40. (PMID: 24935276)
J Hepatol. 2014 Jul;61(1):3-4. (PMID: 24727122)
Clin Cancer Res. 2014 Mar 15;20(6):1623-31. (PMID: 24493832)
J Hepatol. 2014 Jun;60(6):1212-8. (PMID: 24486088)
Biomed Res Int. 2014;2014:194278. (PMID: 24800212)
J Cancer Res Clin Oncol. 2013 Apr;139(4):635-43. (PMID: 23283527)
Liver Int. 2010 Feb;30(2):166-74. (PMID: 19912531)
Contributed Indexing:: Keywords: Hepatocellular carcinoma; Preoperative; Review; Surgical resection; Transarterial chemoembolization
Entry Date(s):: Date Created: 20150128 Date Completed: 20150127 Latest Revision: 20201001
Update Code:: 20240104
PubMed Central ID:: PMC4295192
DOI:: 10.4254/wjh.v7.i1.40
PMID:: 25624995
: Czasopismo naukowe

Hepatocellular carcinoma (HCC) is one of the few cancers whose incidence has been continually increasing over recent years. Resection of HCC offers the only hope for cure. However, recurrences are common in patients who have undergone resection. In our opinion, the effectiveness with which transarterial chemoembolization (TACE) as a neoadjuvant therapy for resectable HCC prevents recurrence and prolongs survival has not been conclusively demonstrated. All published meta-analyses have consistently failed to demonstrate that preoperative TACE improves the prognosis of resectable HCC. We believe that these published articles have several limitations and have our own views about the results of meta-analyses. It is very important that the scientific community shed more light on the pathogenesis of HCC and relate this to choice of therapy. This review mainly concerns our understanding of preoperative TACE for resectable HCC and briefly addresses desirable directions for future studies.

Informacja